CNS PHARMACEUTICALS INC. - COMMON STOCK

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Receives Average Rating of "Moderate Buy" from Analysts

25 Nov 2024 02:21:10 By Buzz FX

Zacks Research Raises Earnings Estimates for Canadian Solar

25 Nov 2024 02:21:10 By Buzz FX

Intuit Inc. (NASDAQ:INTU) Given Average Rating of "Moderate Buy" by Analysts

25 Nov 2024 02:21:10 By Buzz FX

Quanta Services, Inc. (NYSE:PWR) Receives Average Recommendation of "Moderate Buy" from Analysts

25 Nov 2024 02:21:10 By Buzz FX

Murphy Oil Co. (NYSE:MUR) Given Average Recommendation of "Hold" by Analysts

25 Nov 2024 02:21:10 By Buzz FX

Paychex, Inc. (NASDAQ:PAYX) Given Average Rating of "Reduce" by Analysts

25 Nov 2024 02:21:10 By Buzz FX

DXC Technology (NYSE:DXC) Given Average Recommendation of "Reduce" by Brokerages

25 Nov 2024 02:21:10 By Buzz FX

Samsara Inc. (NYSE:IOT) Receives Average Rating of "Hold" from Analysts

25 Nov 2024 02:21:10 By Buzz FX

Xylem Inc. (NYSE:XYL) Given Average Rating of "Moderate Buy" by Analysts

25 Nov 2024 02:21:10 By Buzz FX

Cloudflare, Inc. (NYSE:NET) Receives Consensus Recommendation of "Hold" from Analysts

25 Nov 2024 02:21:10 By Buzz FX

NMI Holdings, Inc. (NASDAQ:NMIH) Receives Average Recommendation of "Moderate Buy" from Brokerages

25 Nov 2024 02:21:10 By Buzz FX

Stellar Shines: XLM Rockets Over 180% In Just One Week – Details

25 Nov 2024 02:20:21 By Buzz FX

Jim Cramer on MicroStrategy Incorporated (MSTR): ‘I’ve Gotta Tell You, It’s A Bitcoin Play’

25 Nov 2024 02:17:21 By Buzz FX

Equinor ASA: Announcement of cash dividend per share in NOK for second quarter 2024 | Morningstar

25 Nov 2024 02:17:21 By Buzz FX

Considerations to be made in light of US vote outcome

25 Nov 2024 02:11:21 By Buzz FX

Curtiss-Wright Q4 EPS Forecast Decreased by Zacks Research

25 Nov 2024 02:11:09 By Buzz FX

National Bank Financial Expects Reduced Earnings for Metro

25 Nov 2024 02:11:09 By Buzz FX

Zacks Research Lifts Earnings Estimates for Vulcan Materials

25 Nov 2024 02:11:09 By Buzz FX

Zacks Research Has Pessimistic Outlook of IQVIA Q1 Earnings

25 Nov 2024 02:11:09 By Buzz FX

Q1 EPS Estimate for Sage Therapeutics Increased by Analyst

25 Nov 2024 02:11:09 By Buzz FX